Trial Profile
Effects of combination drugs of calcium channel blockers and angiotensin II receptor blockers on blood pressure, lipid profile, and glucose metabolism in hypertensive patients with glucose intolerance.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2011
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Candesartan cilexetil (Primary) ; Telmisartan (Primary)
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms J-METS
- 07 Nov 2011 New trial record